Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: A prospective randomized placebo-controlled double-blind cross-over study

Digestion

Volumn 80, Issue 4, 2009, Pages 260-266

  Niwa, Yasumasa ^a   Nakamura, Masanao ^a   Miyahara, Ryoji ^a   Ohmiya, Naoki ^a   Watanabe, Osamu ^a   Ando, Takafumi ^a   Kawashima, Hiroki ^a   Itoh, Akihiro ^a   Hirooka, Yoshiki ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Geranylgeranylacetone; Healthy subjects; Intestinal injury; NSAIDs; Rabeprazole; Video capsule endoscopy

Indexed keywords

ANTIOXIDANT; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; RABEPRAZOLE; TEPRENONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH EROSION; STOMACH MUCOSA LESION; STOMACH ULCER; TREATMENT DURATION; VIDEOENDOSCOPY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CAPSULE ENDOSCOPY; CROSS-OVER STUDIES; DICLOFENAC; DITERPENES; DOUBLE-BLIND METHOD; HUMANS; MALE; PEPTIC ULCER; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70350059067     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236032     Document Type: Article

References (27)

1. Iddan G, Meron G, Glukhovsky A, Swain P: Wireless capsule endoscopy. Nature 2000; 405: 417.
2. Yamamoto H, Yano T, Kita H, Sunada K, Ido K, Sugano K: New system of double-balloon enteroscopy for diagnosis and treatment of small intestinal disorders. Gastroenterology 2003; 125: 1556.
3. Nakamura M, Niwa Y, Ohmiya N, Miyahara R, Ohashi A, Itoh A, Hirooka Y, Goto H: Preliminary comparison of capsule endoscopy and double-balloon enteroscopy in patients with suspected small-bowel bleeding. Endoscopy 2006; 38: 59-66.
4. Graham DY, Opekun AR, Willingham FF, Qureshi WA: Visible small intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005; 3: 55-59.
5. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I: A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-1178.
6. Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, Bjarnason I: Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a crosssectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007; 5: 1040-1045.
7. Bjarnason I, Smethurst P, Clark P, Menzies I, Levi J, Peters T: Effect of on prostaglandin indomethacin-induced increased intestinal permeability in man. Scand J Gastroenterol 1989; 164(suppl):97-103.
8. Yanaka A, Zhang S, Sato D, Tauchi M, Suzuki H, Shibahara T, Matsui H, Nakahara A, Hyodo I: Geranylgeranylacetone protects the human gastric mucosa from diclofenacinduced injury via induction of heat-shock protein-70. Digestion 2007; 75: 148-155.
9. Sakamoto C, Ogoshi K, Saigenji K, Narisawa R, Nagura H, Mine T, Tada M, Umegaki E, Maekawa T, Maekawa R, Maeda K: Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: a randomized, double-blind trial in Japan. Digestion 2007; 75: 215-224.
10. Miyake K, Tsukui T, Shinji Y, Shinoki K, Hiratsuka T, Nishigaki H, Futagami S, Wada K, Gudis K, Iwakiri K, Yamada N, Sakamoto C: Teprenone, but not H 2 -receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori -induced interleukin -in MKN28 gastric epithelial cell lines. Helicobacter 2004; 9: 130-137.
11. Hirakawa T, Rokutan K, Nikawa T, Kishi K: Geranylgeranylacetone induces heat-shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996; 111: 345-357.
12. Tsuruma T, Yagihashi A, Koide S, Araya J, Tarumi K, Watanabe N, Hirata K: Geranylgeranylacetone induces heat-shock protein-in rat small intestine. Transplant Proc 1999; 31: 572-573.
13. Iwata T, Nowak G, Yamamoto S, Sharma A, Kumagai-Braesch M, Rokutan K, Shimada M, Ericzon B-G: Single oral administration of geranylgeranylacetone induces heat-shock protein-70 and prevents ischemia reperfusion injury in rat small intestine. Gastroenterology 2007; 132(suppl 2):A-570.
14. Wallmark B, Jaresten BM, Larsson H, Ryberg B, Brändström A, Fellenius E: Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion. Am J Physiol 1983; 245: G64-G71.
15. Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, Okanoue T, Yoshikawa T: Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 2006; 17: 89-93.
16. Pozzoli C, Menozzi A, Grandi D, Solenghi E, Ossiprandi MC, Zullian C, Bertini S, Cavestro GM, Coruzzi G: Protective effects of proton pump inhibitors against indomethacin- induced lesions in the rat small intestine. Naunyn Schmiedebergs Arch Pharmacol 2007; 374: 283-291.
17. Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, Hirooka Y, Goto H: Efficacy of rebamipide for diclofenac-induced small intestinal mucosal injuries in healthy subjects: a prospective, randomized, doubleblinded, placebo-controlled, cross-over study. J Gastroenterol 2008; 43: 270-276.
18. Kamada T, Hata J, Kushinoki H, Sugio K, Tanimoto T, Mihara M, Kido S, Dongmei Q, Haruma K: Endoscopic characteristics and Helicobacter infection in NSAIDs-associated gastric ulcers. J Gastroenterol Hepatol 2006: 21: 98-102.
19. Peter S, Heuss LT, Beglinger C, Degen L: Capsule endoscopy of the upper gastrointestinal tract - the need for a second endoscopy. Digestion. 2005; 72: 242-247.
20. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3: 133-141.
21. Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C, Goto H, Nakase H, Tanaka S, Matsui T, Sugano K, Iida M: Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008; 43: 490-496.
22. Somasundaram S, Rafi S, Hayllar J, Sigthorsson G, Jacob M, Price AB, Macpherson A, Mahmod T, Scott D, Wrigglesworth JM, Bjarnason I: Mitochondrial damage: a possible mechanism of the 'topical' phase of NSAID induced injury to the rat intestine. Gut 1997; 41: 344-353.
23. Evans SM, Whittle BJ: Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 2001; 429: 287-296.
24. Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, Palizban A, Pombo J, Watts J, Morham SG, Bjarnason I: COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology 2002; 122: 1913-1923.
25. Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Oshitani N, Asahara T, Nomoto K, Takeuchi K, Arakawa T: Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57: 181-187.
26. Fujimori S, Seo T, Gudis K, Ehara A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C: Prevention of nonsteroidal anti-inflammatory drug-induced small intestinal injury by prostaglandin: a pilot randomizied controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009; 69: 1339-1346.
27. Yokota A, Ohno R, Takahira Y, Tanaka A, Takeuchi K: Protective effect of teprenone against indomethacin-induced small intestinal lesions in rats. Jpn Pharmacol Ther 2005; 33: 51-61.